These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9169498)

  • 1. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand.
    Takada M; Nadeau KC; Shaw GD; Marquette KA; Tilney NL
    J Clin Invest; 1997 Jun; 99(11):2682-90. PubMed ID: 9169498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.
    Dulkanchainun TS; Goss JA; Imagawa DK; Shaw GD; Anselmo DM; Kaldas F; Wang T; Zhao D; Busuttil AA; Kato H; Murray NG; Kupiec-Weglinski JW; Busuttil RW
    Ann Surg; 1998 Jun; 227(6):832-40. PubMed ID: 9637546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding.
    Takada M; Nadeau KC; Shaw GD; Tilney NL
    Transplantation; 1997 Dec; 64(11):1520-5. PubMed ID: 9415550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness: indefinite kidney allograft survival by treatment with a soluble P-selectin ligand and low-dose cyclosporine in combination.
    Kusaka M; Zandi-Nejad K; Kato S; Beato F; Nagano H; Shaw GD; Tilney NL
    Transplantation; 1999 May; 67(9):1255-61. PubMed ID: 10342318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background.
    Dragun D; Hoff U; Park JK; Qun Y; Schneider W; Luft FC; Haller H
    Kidney Int; 2000 Nov; 58(5):2166-77. PubMed ID: 11044238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of severe ischemia/reperfusion injury in rat kidney grafts by a soluble P-selectin glycoprotein ligand.
    Fuller TF; Sattler B; Binder L; Vetterlein F; Ringe B; Lorf T
    Transplantation; 2001 Jul; 72(2):216-22. PubMed ID: 11477341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand.
    Gasser M; Waaga AM; Kist-Van Holthe JE; Lenhard SM; Laskowski I; Shaw GD; Hancock WW; Tilney NL
    J Am Soc Nephrol; 2002 Jul; 13(7):1937-45. PubMed ID: 12089391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cellular and molecular changes in ischemia/reperfusion injury: inhibition by a selectin antagonist, P-selectin glycoprotein ligand-1.
    Takada M; Nadeau KC; Shaw GD; Tilney NL
    Transplant Proc; 1997; 29(1-2):1324-5. PubMed ID: 9123325
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury.
    Takada M; Chandraker A; Nadeau KC; Sayegh MH; Tilney NL
    J Clin Invest; 1997 Sep; 100(5):1199-203. PubMed ID: 9276737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.
    Lien YH; Yong KC; Cho C; Igarashi S; Lai LW
    Kidney Int; 2006 May; 69(9):1601-8. PubMed ID: 16572108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion.
    Koo DD; Welsh KI; Roake JA; Morris PJ; Fuggle SV
    Am J Pathol; 1998 Aug; 153(2):557-66. PubMed ID: 9708815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor.
    Pratschke J; Kofla G; Wilhelm MJ; Vergopoulos A; Laskowski I; Shaw GD; Tullius SG; Volk HD; Neuhaus P; Tilney NL
    Ann Surg; 2001 Dec; 234(6):732-40. PubMed ID: 11729379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney.
    Azuma H; Nadeau K; Takada M; Mackenzie HS; Tilney NL
    Transplantation; 1997 Jul; 64(2):190-7. PubMed ID: 9256172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
    Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
    Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intraportal prostaglandin E1 on adhesion molecule expression, inflammatory modulator function, and histology in canine hepatic ischemia/reperfusion injury.
    Hafez T; Moussa M; Nesim I; Baligh N; Davidson B; Abdul-Hadi A
    J Surg Res; 2007 Mar; 138(1):88-99. PubMed ID: 17174338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The affection and significance of NO on the expression of P-selectin in renal injury following hind limb ischemia/reperfusion in rats].
    Duan GX; Zhao LJ; Zhang LY; Dong SY; Zhou HX; Zhang N; Wang YH; Men XL; Li HJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 Nov; 23(4):456-61. PubMed ID: 21180132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
    Xia G; Martin AE; Besner GE
    J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-adhesive therapy on kidney biomarkers of ischemia reperfusion injury in human deceased donor kidney allografts.
    Cheadle C; Watkins T; Ehrlich E; Barnes K; Gaber AO; Hemmerich S; Rabb H
    Clin Transplant; 2011; 25(5):766-75. PubMed ID: 21114535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
    Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion.
    Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.